Double enzyme co-loaded nanospheres for AFP detection and preparation method thereof, and AFP detection method

By loading glucose oxidase and horseradish peroxidase on magnetic mesoporous silica nanospheres of core-shell structure, the detection sensitivity of biological enzymes in the prior art is solved by using the super-large specific surface area and superparamagnetic properties of the mesoporous. The problem of low results enables more efficient and stable alpha-fetoprotein AFP detection.

CN114384237BActive Publication Date: 2024-11-22FUDAN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111583707.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-22
Publication Date
2024-11-22
Estimated Expiration
2041-12-22

AI Technical Summary

Technical Problem

In the prior art, the sensitivity of biological enzyme detection is low, and the detection instrument is large in size and the reagents are expensive, so it is not suitable for single portion or small batch testing. It is especially difficult to promote and use in grassroots hospitals with backward economic conditions.

Method used

The core-shell structure magnetic mesoporous silica nanospheres are loaded with glucose oxidase and horseradish peroxidase, and the super-paramagnetic characteristics of the mesoporous can improve the load of enzymes and the enrichment efficiency of target objects. , thereby improving detection signal strength and sensitivity.

Benefits of technology

It significantly improves the sensitivity and accuracy of AFP detection of alpha-fetoprotein, reduces background interference introduced by biological samples, and has more stable detection results, which are suitable for small batch detection needs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114384237B_ABST
    Figure CN114384237B_ABST
Patent Text Reader

Abstract

The present invention provides a dual-enzyme co-loaded nanosphere for alpha-fetoprotein (AFP) detection and a preparation method, a probe, a kit and an AFP detection method, which belong to the field of biological detection and enzyme-loaded materials. The dual-enzyme co-loaded nanosphere includes: a core-shell structure magnetic mesoporous silica nanosphere, and glucose oxidase GoD and horseradish peroxidase HRP distributed in the mesoporous channels; wherein the core-shell structure has magnetic core particles and a silica shell structure distributed with mesoporous channels; the magnetic core particles are used to enrich AFP in serum samples through magnetic separation; GoD and HRP are used to catalyze substrate color development. The present invention increases the enzyme loading through the core-shell structure mesoporous nanosphere, and also enriches the target through superparamagnetic properties, reduces the background interference introduced by the biological sample, and increases the signal strength of the detection, thereby increasing the detection sensitivity; at the same time, the detection stability is guaranteed, and the detection accuracy and precision are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biological detection and enzyme loading materials, and particularly relates to a double-enzyme co-loaded nanosphere for AFP detection and a preparation method thereof, and an AFP detection method. Background Art

[0002] Alpha-fetoprotein (AFP) is composed of 591 amino acids and is a glycoprotein synthesized by the liver and yolk sac in the early stages of fetal development. The AFP content in normal human serum is low, at 10 ng•mL. -1 -20 ng•mL -1 When liver cells develop malignant changes, the concentration of AFP will rise sharply. It is a common marker for the diagnosis of primary liver cancer in clinical practice, with a diagnosis rate of about 70% for liver cancer. It is also closely related to the occurrence and development of various tumors. When the AFP content in serum is greater than 200 ng•mL within 2 months, -1 Or greater than 400 ng•mL within one month -1 Therefore, the detection of AFP can assist in the diagnosis of liver cancer.

[0003] In the prior art, the detection methods of AFP in serum include: Enzyme-Linked Immunosorbent Assay (ELISA) colorimetric method, magnetic particle chemiluminescence method, cyclic voltammetry and linear sweep voltammetry, etc. Among them, magnetic particle chemiluminescence method, cyclic voltammetry and linear sweep voltammetry have the advantages of high detection sensitivity and high automation, but their detection instruments are large in size and reagents are expensive, which are not suitable for single-person or small-batch detection, especially in grassroots hospitals, community clinics, health centers, etc. with backward economic conditions, and cannot be widely promoted and used; while the ELISA method uses a 96-well plate as a carrier, through a simple fixed antibody as a capture platform, and then uses a horseradish peroxidase (HRP) labeled antibody as a detection probe to catalyze the substrate to develop color, which has the advantages of simple operation and easy interpretation of detection results, but its detection sensitivity is low. Summary of the invention

[0004] The embodiments of the present invention aim to solve the problems of low enzyme loading and low detection sensitivity in bio-enzyme detection technology, and provide a dual-enzyme co-loaded nanosphere for AFP detection and a preparation method thereof, as well as an AFP detection method. The dual enzymes are loaded into core-shell structured magnetic macroporous mesoporous silica nanospheres, so that not only more enzymes are loaded through the ultra-large specific surface area of ​​the macroporous mesoporous silica, but also the target is enriched through the superparamagnetic property, so as to improve the signal intensity of bio-enzyme detection and thus improve the detection sensitivity.

[0005] In order to achieve the above purpose, the embodiment of the present invention adopts the following technical solution:

[0006] In a first aspect, an embodiment of the present invention provides a dual-enzyme co-loaded nanosphere for AFP detection, wherein the nanosphere comprises: a core-shell structured magnetic mesoporous silica nanosphere, and glucose oxidase GoD and horseradish peroxidase HRP distributed in the mesoporous channels;

[0007] The core-shell structure comprises magnetic core particles and a silica spherical shell structure with distributed mesoporous channels; the magnetic core particles are used to enrich AFP in a serum sample through magnetic separation; and the glucose oxidase GoD and horseradish peroxidase HRP are used to catalyze substrate color development.

[0008] When a carrier loaded with an enzyme is used for biological detection, the amount of enzyme loaded will directly affect the detection sensitivity. The carriers used in the prior art generally load the enzyme on the surface of nanoparticles. The amount of loaded enzyme is limited by the specific surface area of ​​the nanoparticles, resulting in low detection sensitivity, affecting the accuracy and precision of the detection results.

[0009] In this embodiment, the dual enzyme used for AFP detection is loaded in the mesoporous channels of the magnetic mesoporous silica nanospheres with a core-shell structure, which not only loads more enzymes through the large specific surface area of ​​the mesopores, but also, because the core of the core-shell structure has magnetic properties, it can separate and enrich the target AFP, greatly improving the detection sensitivity of the target. Thus, the core-shell structure magnetic mesoporous silica nanospheres magnetically separate and enrich the target AFP in serum, and the loaded dual enzyme catalyzes the substrate to develop color, and the AFP content is detected by biological coupling AFP capture antibody, and the bio-labeling process is simple and highly sensitive. The magnetic core particles use Fe3O4 magnetic nanoparticles.

[0010] Furthermore, the particle size of the magnetic core particles is 230-250 nm, and the thickness of the silica shell structure layer with mesoporous channels is 50-200 nm.

[0011] Furthermore, the feed ratio of GoD to HRP is 1:1.

[0012] The present invention also provides a method for preparing a dual-enzyme co-loaded nanosphere for AFP detection, comprising the following steps:

[0013] Step S101, dissolving ferric chloride, trisodium citrate and sodium acetate in ethylene glycol, and synthesizing 230-250 nm Fe3O4 magnetic nanoparticles by a solvothermal method;

[0014] Step S102, using the interface co-assembly method to prepare a mesoporous silica shell structure layer outside the magnetic nanoparticles; specifically, the Fe3O4 magnetic nanoparticles are dispersed in a mixed solution of ethanol and water, tetraethyl orthosilicate (TEOS) is used as a silicon source, hexadecyltrimethylammonium bromide (CTAB) is used as a template, an organic reagent is used as a pore expander, and an alkaline reagent is used as a catalyst, and a core-shell structured magnetic mesoporous silica nanospheres are obtained by water bath reaction under mechanical stirring conditions; in this step, the nanospheres can also be modified by epoxy groups, and the specific process is as follows: 3-(2,3-propylene oxide)propyltrimethoxysilane (GLYMO) is used to modify the core-shell structured magnetic mesoporous silica nanospheres to obtain epoxy group-functionalized core-shell structured magnetic macroporous mesoporous silica nanospheres;

[0015] Step S103, glucose oxidase GoD and horseradish peroxidase HRP are coupled to the mesoporous channels of the shell structure layer by covalent coupling method. The specific coupling parameters are: reaction at 37° C. for 2 h.

[0016] In a second aspect, an embodiment of the present invention further provides a probe for detecting AFP, wherein the probe comprises the above-mentioned nanosphere and an AFP capture antibody coupled to the nanosphere.

[0017] Furthermore, the content of the AFP capture antibody in the probe is 1‰ by mass fraction.

[0018] In a third aspect, an embodiment of the present invention further provides an ELISA plate for AFP detection, wherein the ELISA plate is obtained by the following method:

[0019] Use 0.05 mol•L -1 Phosphate buffer at pH 8.6 was used as the coating solution to fix the AFP detection antibody on the ELISA plate, and then the plate was washed with a washing solution (PBS at pH 7.4 with 0.5% Tween 20 added, PBST), and then blocked with bovine serum albumin (BSA); after patting dry, it was placed in a constant temperature room (25°C) to dry, and an ELISA plate for alpha-fetoprotein AFP detection was obtained; the ELISA plate was vacuum-sealed and stored at 4°C.

[0020] In a fourth aspect, an embodiment of the present invention further provides an ELISA kit for AFP detection, the kit comprising the probe as described above, an ELISA plate coated with an AFP detection antibody, a working solution (phosphate buffered saline at pH 7.4, PBS), a glucose solution, a chromogenic substrate (3,3',5,5'-tetramethylbenzidine, TMB), a stop solution and a washing solution (PBS supplemented with 0.5% Tween 20, PBST).

[0021] The ELISA kit provided in this embodiment is different from the ELISA kit labeled with HRP. The ELISA kit labeled with HRP directly catalyzes the color development of the TMB substrate in the presence of H2O2. In the ELISA kit provided in this embodiment, the dual-enzyme co-loaded nanospheres are simultaneously loaded with GoD and HRP, wherein GoD first catalyzes the oxidation of the substrate glucose to produce H2O2, and then HRP catalyzes the oxidation of the color-developing substrate with H2O2 to produce a color change, which has better stability than the ELISA kit labeled with HRP and is less disturbed by the environment. At the same time, the dual-enzyme co-loaded nanospheres described in this embodiment have superparamagnetic properties, which can enrich the target in the sample, thereby reducing the background interference introduced by the biological sample and significantly improving the detection sensitivity.

[0022] When the ELISA kit is used to detect alpha-fetoprotein AFP, the method comprises the following steps:

[0023] Step S201, catalyzing the oxidation of the color substrate in the ELISA kit by the glucose oxidase GoD and horseradish peroxidase HRP on the dual-enzyme co-loaded nanospheres;

[0024] Step S202, stop color development with a stop solution and read the color development signal.

[0025] Furthermore, the oxidation color development process of step S201 specifically includes: diluting the probe with a working solution, mixing it with the serum sample to be tested, and then adding it to the ELISA plate coated with the AFP detection antibody, incubating for 1-3 hours, washing 3 times with a washing solution, and then adding a glucose solution; using GoD to catalyze the oxidation of glucose to produce hydrogen peroxide (H2O2), and HRP to catalyze the oxidation of H2O2 to a color development substrate such as TMB to produce a color signal. The signal can be observed by the naked eye, or the absorbance value can be quantitatively read using an ELISA instrument.

[0026] The present invention has the following beneficial effects:

[0027] The embodiments of the present invention provide a dual-enzyme co-loaded nanosphere, probe, ELISA kit and AFP detection method for AFP detection. By loading dual enzymes into core-shell structured magnetic macroporous mesoporous silica nanospheres, not only more enzymes are loaded through the ultra-large specific surface area of ​​macroporous mesoporous silica, but also the target is enriched through the superparamagnetic property, thereby reducing the background interference introduced by biological samples, improving the signal strength of biological enzyme detection, and thus improving the detection sensitivity; and the detection of alpha-fetoprotein AFP has better stability, is less affected by environmental interference, and improves the detection accuracy and precision. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other accompanying drawings can be obtained based on these accompanying drawings without paying creative work.

[0029] Figure 1 This is a scanning electron microscope image of the Fe3O4 magnetic core synthesized in Example 1 of the present invention.

[0030] Figure 2 This is a transmission electron microscope image of the Fe3O4 magnetic core synthesized in Example 1 of the present invention.

[0031] Figure 3 This is a scanning electron microscope image of the core-shell structured magnetic mesoporous silica nanospheres synthesized in Example 1 of the present invention.

[0032] Figure 4 This is a transmission electron microscopy image of the core-shell structured magnetic mesoporous silica nanospheres synthesized in Example 1 of the present invention.

[0033] Figure 5 This is the standard curve for detecting AFP using a probe with a silica shell thickness of 60 nm in Example 1 of the present invention.

[0034] Figure 6 This is a transmission electron microscopy image of the core-shell structured magnetic mesoporous silica nanospheres synthesized in Example 2 of the present invention. DETAILED DESCRIPTION

[0035] The technical problems, technical solutions and advantages of the present invention are described in detail below with reference to exemplary embodiments. The exemplary embodiments described below are only used to explain the present invention and cannot be interpreted as limiting the present invention.

[0036] Those skilled in the art will understand that, unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as generally understood by those skilled in the art in the art to which the present invention belongs. It should also be understood that terms such as those defined in common dictionaries should be understood to have meanings consistent with the meanings in the context of the prior art, and will not be interpreted with idealized or overly formal meanings unless defined herein.

[0037] Example 1

[0038] The present embodiment provides a dual-enzyme co-loaded nanosphere for detecting alpha-fetoprotein (AFP), wherein the nanosphere comprises: a core-shell structured magnetic mesoporous silica nanosphere, and glucose oxidase GoD and horseradish peroxidase HRP distributed in the mesoporous channels; the core-shell structure comprises a magnetic core particle and a silica shell structure distributed with mesoporous channels; the magnetic core particle is used to enrich AFP in a serum sample, and the AFP is enriched in the shell structure and the mesoporous channels; the glucose oxidase GoD and horseradish peroxidase HRP are used to catalyze a chromogenic substrate.

[0039] The magnetic core particles are Fe3O4 magnetic nanoparticles, and the synthesis process is as follows: FeCl3 (0.65 g, 4.0 mmol) and trisodium citrate (0.20 g, 0.68 mmol) are dissolved in ethylene glycol (20 mL), and then 1.20 g of sodium acetate is added by stirring; the mixture is vigorously stirred for 30 min, and then sealed in a stainless steel autoclave with a polytetrafluoroethylene liner and a capacity of 50 mL; the autoclave is heated at 200°C and maintained for 10 h, and then cooled to room temperature to obtain a black product. The black product is washed several times with ethanol and deionized water to obtain Fe3O4 magnetic nanoparticles. Figure 1 and Figure 2 shown.

[0040] The thickness of the silica shell structure layer is 60 nm, and the preparation process is as follows: core-shell magnetic macroporous mesoporous silica nanospheres with suitable magnetic properties and shell thickness were synthesized by interfacial co-assembly method. First, 100 mg of Fe3O4 nanoparticles were dispersed in 50 mL of CTAB solution (10% aqueous solution, w / v) by ultrasound. Then, 1 mL of concentrated ammonia (28 wt%), 30 mL of cyclohexane and 1 mL of tetraethyl orthosilicate were added to the dispersed solution under continuous magnetic stirring at 45 ° C overnight. Finally, the synthesized nanospheres were collected after washing three times with 50% ethanol. Figure 3 and Figure 4 As shown, through the above process, core-shell structured magnetic mesoporous silica nanospheres having a magnetic core particle and a silica spherical shell structure with distributed mesoporous channels are obtained.

[0041] The preparation process of the glucose oxidase GoD and horseradish peroxidase HRP distributed in the mesoporous channels is as follows: 15 mg of core-shell structured magnetic macroporous mesoporous silica nanospheres are dispersed in 1 mL of NH4HCO3 solution (25 mmol•L -1 , pH=8, containing 1.5mgGoD and 1.5mgHRP).

[0042] Based on the dual-enzyme co-loaded nanospheres for AFP detection, this embodiment also provides a probe for AFP detection. The preparation process of the probe is based on the above-mentioned NH4HCO3 solution mixture dispersed with dual-enzyme co-loaded nanospheres, 0.5 mg and 1 mg AFP capture antibody are added to the mixture respectively, and gently shaken at 37°C in the dark for 2 hours. After removing excess GoD, HRP and AFP capture antibodies, the nanospheres loaded with GoD, HRP and AFP capture antibodies are collected by magnetic separation and dispersed in 3mL PBS (10 mmol•L -1 , pH 7.4; containing 5% bovine serum albumin (w / v%)) for further use.

[0043] Based on the probe, this embodiment also provides an ELISA plate for AFP detection. The preparation process of the ELISA plate is as follows: 0.05 mol·L -1 Phosphate buffer at pH 8.6 was used as the coating solution. AFP detection antibody (commercially available) was diluted to 15 µg•mL -1 , 100 µL / well, coated overnight at 4°C; washed three times with PBST, then washed with PBS (10 mmol•L -1 After washing once with 3% BSA (dissolved in 10 mmol·L -1 The plate was blocked with PBS (pH 7.4, 300 μL / well) for 1 h, then washed three times with PBST and washed with PBS (10 mmol•L -1 , pH 7.4) and then placed in a constant temperature room (25°C) to dry to obtain an ELISA plate; after the sample inspection is qualified, the ELISA plate is vacuum sealed and stored at 4°C.

[0044] Based on the probe and ELISA plate, this embodiment also provides an ELISA kit for AFP detection, which includes the probe as described above, an ELISA plate coated with an AFP detection antibody, a phosphate buffer of pH 7.4, a glucose solution, 3,3',5,5'-tetramethylbenzidine TMB, a stop solution, and a washing solution PBST formed by PBS added with 0.5% Tween 20.

[0045] When the ELISA kit is used to detect alpha-fetoprotein AFP, the specific process is as follows: 50 μL of dual-enzyme co-loaded core-shell structured magnetic macroporous mesoporous silica nanospheres (5 μg•mL -1 ) and 50 μL of serially diluted AFP standard solution or serum (PBS, 10 mmol•L -1, pH 7.4, 50 μL / well) was added to the wells and placed at 37°C for 2 h. After washing again three times with PBST and once with ultrapure water, glucose solution (50 mmol•L -1 ), 100 μL / well, for 45 min. Finally, add ethanol-diluted TMB substrate (10 mmoL•L -1 After 20 min of reaction, 650 nm TMB color stop solution (50 μL / well) was added to the wells. The absorbance at 650 nm was then read by naked eye or recorded on a Cytation 3 multi-function microplate reader.

[0046] like Figure 5 As shown in Figure 2, the detection sensitivity of the prepared ELISA kit was calculated by substituting the absorbance value into the established standard curve. The detection limit of AFP detection using the core-shell structured magnetic macroporous mesoporous silica nanosphere probe with a shell thickness of 60 nm was 0.08 ng•mL -1 .

[0047] Example 2

[0048] This embodiment is basically the same as Example 1, except that the thickness of the silica shell structure layer is 200 nm, and the preparation process is as follows: core-shell magnetic macroporous mesoporous silica nanospheres with suitable magnetic properties and shell thickness are synthesized by interfacial co-assembly method. First, 100 mg of Fe3O4 nanoparticles are dispersed in 50 mL of CTAB solution (10% aqueous solution, w / v) by ultrasound. Then, 1 mL of concentrated ammonia (28 wt%), 30 mL of cyclohexane and 4 mL of tetraethyl orthosilicate are added to the dispersed solution under continuous magnetic stirring at 45 ° C overnight. Finally, the synthesized nanospheres are collected after washing three times with 50% ethanol, as shown in FIG. Figure 6 shown.

[0049] Example 3

[0050] This example is basically the same as Example 1, except that the prepared silica shell structure layer with a thickness of 60 nm is functionalized by epoxy group GLYMO, and the specific process is as follows: 0.2 g of core-shell structured magnetic macroporous mesoporous silica nanospheres with silica shell thicknesses of 60 nm and 200 nm are dispersed in a mixture of 100 mL toluene and 0.2 g / 0.8 g GLYMO. The mixture is stirred at room temperature for 1 h, then heated to 65 ° C and stirred for 8 h. The obtained product is washed several times with anhydrous ethanol and vacuum dried at 50 ° C overnight, and the core-shell structured magnetic macroporous mesoporous silica nanospheres functionalized with epoxy groups are collected for further use.

[0051] The above is a preferred embodiment of the present invention. It should be noted that the present invention is not limited to the exemplary embodiments disclosed above. The essence of the description is only to help those skilled in the relevant field to comprehensively understand the specific details of the present invention. For those skilled in the art, without departing from the principles of the present invention, several improvements and modifications made within the technical scope disclosed by the present invention, and changes or replacements that can be easily thought of, should be covered within the protection scope of the present invention.

Claims

1. A dual-enzyme co-loaded nanosphere for alpha-fetoprotein (AFP) detection. It is characterized in that The nanospheres include: core-shell structured magnetic mesoporous silica nanospheres, and glucose oxidase GoD and horseradish peroxidase HRP distributed in the mesoporous channels, GoD and HRP are loaded on the carrier in a covalently coupled manner, and the feed ratio of GoD to HRP is 1:1; wherein, The core-shell structure has magnetic core particles and a silica shell structure with distributed mesoporous channels; the magnetic core particles are used to enrich AFP in a serum sample through magnetic separation; the glucose oxidase GoD and horseradish peroxidase HRP are used to catalyze substrate color development.

2. The double enzyme co-loaded nanosphere for AFP detection according to claim 1, It is characterized in that The particle size of the magnetic core particles is 230-250 nm, and the thickness of the silica spherical shell structure layer with mesoporous channels is 50-200 nm.

3. A method for preparing dual-enzyme co-loaded nanospheres for AFP detection, It is characterized in that The steps include: Step S101, dissolving ferric chloride, trisodium citrate and sodium acetate in ethylene glycol, and synthesizing 230-250 nm Fe 3 O 4 Magnetic nanoparticles; Step S102, using an interface co-assembly method to prepare a mesoporous silica shell structure layer outside the magnetic nanoparticles; 3 O 4 Magnetic nanoparticles are dispersed in a mixed solution of ethanol and water, tetraethyl orthosilicate TEOS is used as a silicon source, hexadecyltrimethylammonium bromide CTAB is used as a template, an organic reagent is used as a pore-enlarging agent, and an alkaline reagent is used as a catalyst. Under mechanical stirring conditions, a water bath reaction is performed to obtain magnetic mesoporous silica nanospheres with a core-shell structure. Step S103, coupling glucose oxidase GoD and horseradish peroxidase HRP into the mesoporous channels of the shell structure layer by a covalent coupling method; The feed ratio of GoD and HRP was 1:

1.

4. The method for preparing the dual-enzyme co-loaded nanospheres according to claim 3, It is characterized in that In the step S102, the magnetic mesoporous silica nanospheres are modified with epoxy groups, and the core-shell structured magnetic mesoporous silica nanospheres are modified with 3-(2,3-propylene oxide)propyltrimethoxysilane to obtain epoxy group-functionalized core-shell structured magnetic macroporous mesoporous silica nanospheres.

5. A probe for AFP detection, It is characterized in that The probe comprises the nanosphere according to any one of claims 1 to 3, and an AFP capture antibody coupled to the nanosphere.

6. The probe for detecting alpha-fetoprotein (AFP) according to claim 5, It is characterized in that The content of the AFP capture antibody in the probe is 1‰ by mass fraction.

7. An ELISA kit for detecting AFP, It is characterized in that The kit comprises the probe as claimed in claim 5 or 6, an ELISA plate coated with an AFP detection antibody, a working solution, a glucose solution, a color development substrate, a stop solution and a washing solution.

8. A method for detecting AFP using the ELISA kit according to claim 7, It is characterized in that The method is for the purpose of non-disease diagnosis and comprises the following steps: Step S201, the glucose oxidase GoD and horseradish peroxidase HRP on the dual-enzyme co-loaded nanospheres carried by the probe catalyze the oxidation of the color substrate in the ELISA kit; Step S202, stop color development with a stop solution and read the color development signal.

9. The AFP detection method according to claim 8, It is characterized in that The oxidation color development process in step S201 specifically includes: diluting the probe with a working solution, mixing it with the serum sample to be tested, and then adding it to the ELISA plate coated with the AFP detection antibody, incubating for 1-3 hours, washing with a washing solution, and adding a glucose solution; using GoD to catalyze the oxidation of glucose to produce hydrogen peroxide H 2 O 2 , and then HRP catalyzed H 2 O 2 The oxidized chromogenic substrate generates a signal, and after adding the stop solution, the AFP content is determined by the color signal.